Argininosuccinate lyase
Argininosuccinate Lyase
Argininosuccinate lyase (ASL) is an enzyme that plays a crucial role in the urea cycle, a series of biochemical reactions that occur in the liver. This enzyme catalyzes the reversible breakdown of argininosuccinate into arginine and fumarate.
Function
Argininosuccinate lyase is essential for the proper functioning of the urea cycle, which is responsible for converting toxic ammonia into urea for excretion from the body. The enzyme's activity ensures the continuation of the cycle by producing arginine, which is further processed to release urea, and fumarate, which enters the citric acid cycle.
Structure
ASL is a homotetramer, meaning it is composed of four identical subunits. Each subunit contains an active site where the conversion of argininosuccinate to arginine and fumarate takes place. The enzyme's structure is highly conserved across different species, indicating its importance in metabolic processes.
Genetic Implications
Mutations in the gene encoding argininosuccinate lyase can lead to a condition known as argininosuccinic aciduria. This genetic disorder is characterized by the accumulation of argininosuccinate in the blood and urine, leading to symptoms such as hyperammonemia, developmental delay, and liver dysfunction.
Clinical Significance
The diagnosis of argininosuccinic aciduria is typically confirmed through genetic testing and the measurement of enzyme activity in liver biopsy samples. Treatment often involves dietary management to reduce ammonia levels and supplementation with arginine to bypass the metabolic block.
Related Enzymes
Argininosuccinate lyase is one of several enzymes involved in the urea cycle. Others include carbamoyl phosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthetase, and arginase. Each enzyme plays a specific role in the conversion of ammonia to urea.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD